Biopharm Asia, Inc. ( PINKSHEETS : BFAR ) is pleased to announce that Biopharm Asia, Inc. received approval for the recently submitted 15c2-11 filing late on Friday Dec 14^th.

The Company will now seek listing with the OTC Bulletin Board at the earliest possible opportunity.

This is a significant step in the growth and development of Biopharm Asia, Inc. The approval and the subsequent OTC listing will allow the company to access additional capital market and investors through new merger and acquisition targets. Biopharm Asia is excited to continue its commitment to increasing transparency, exposure and providing liquidity for its shareholders.

TONGHUA, CHINA--(Marketwire - Dec 18, 2012)